Trending News
News
News
Johns Hopkins Researcher Leads International Effort to Create “Proteinpedia”
A Johns Hopkins researcher has led the effort to compile to date the largest free resource of experimental information about human proteins.
News
Medical Solutions Becomes first UK Commercial Service Provider of Illumina DNA Sequencing and Genotyping Applications
The Board of Medical Solutions plc has announced that it is implementing a new technology platform at its Nottingham laboratory.
News
Online Resource for Peptide Chemists
Activotec has announced the launch of an updated information-rich website.
News
Thermogenesis Announces new Initiative to Address Veterinary Regenerative Medicine
The Company is in the process of completing a research collaboration with UC Davis Collaboration.
News
Vermillion and Johns Hopkins Sign Collaborative Research and License Agreements to Develop Molecular Diagnostic Tests
Vermillion obtains exclusive rights the development of biomarkers that can be applied toward disease detection, classification and monitoring of prevalent cancers.
News
DiscoveRx Corporation Signs Agreement with Cosmo Bio
DiscoveRx Corporation announces the selection of Cosmo Bio as a key distributor for the Japanese territory.
News
Select Biosciences Announces the Availability of Exhibition-only Passes for Screening, ADMET & MedChem Europe
The event will see over 350 people gathering to attend presentations on the latest on biomolecular screening, medicinal chemistry or ADME-toxicology advances.
News
Europe’s most Common Genetic Disease is a Liver Disorder
Researchers discover the origin of hereditary hemochromatosis, a common iron overload disorder, is a genetic defect in the liver.
News
Nara Biosciences Completes Exclusive Licensing Agreement with Boston University
Nara Biosciences has licensed the MyoMouse discovery platform for metabolic and muscle wasting disorder therapies.
News
Amgen and Takeda Announce Exclusive Collaboration in Japan on up to 13 Amgen Clinical Candidates
Under the agreement, Takeda will receive exclusive rights to develop and commercialize select molecules in Japan.
Advertisement